LENZ Therapeutics (LENZ) Amortizatization of Intangibles (2022 - 2026)

LENZ Therapeutics' (LENZ) quarterly Amortizatization of Intangibles came in at $316000.0 in Q1 2026, down 72.13% year-on-year from $1.1 million in Q1 2025, and down 48.03% on a QoQ basis from $608000.0 in Q4 2025.

LENZ Therapeutics (LENZ) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends

LENZ Therapeutics (LENZ) has 5 years of Amortizatization of Intangibles data on file, last reported at $316000.0 in Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles fell 72.13% year-over-year to $316000.0 in Q1 2026; TTM through Mar 2026 was $2.6 million, a 46.86% decrease from a year earlier, with the FY2025 full-year figure at $3.4 million, down 15.14% from the prior year.
  • Amortizatization of Intangibles for Q1 2026 stood at $316000.0, down from $608000.0 in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for LENZ reached as high as $1.4 million in Q4 2024 and fell as low as -$45000.0 in Q1 2022.
  • Historically, Amortizatization of Intangibles has averaged $649937.5 across 5 years, with a median of $585000.0 in 2022.
  • Across the five-year window, Amortizatization of Intangibles soared 4947.37% in 2024 and plunged 72.13% in 2026, its largest moves.
  • Year by year, Amortizatization of Intangibles stood at $1.1 million in 2022, then plunged by 54.42% to $511000.0 in 2023, then jumped by 178.67% to $1.4 million in 2024, then plunged by 57.3% to $608000.0 in 2025, then slumped by 48.03% to $316000.0 in 2026.
  • Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $316000.0 in Q1 2026, $608000.0 in Q4 2025, and $779000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 LENZ Therapeutics 177.61 Mn -80.77 Mn 825,000.00 316,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 316,000.00
Mar 31, 2026 316,000.00
Dec 31, 2025 608,000.00
Dec 31, 2025 608,000.00
Sep 30, 2025 779,000.00
Sep 30, 2025 779,000.00
Jun 30, 2025 888,000.00
Jun 30, 2025 888,000.00
Mar 31, 2025 1.13 Mn
Mar 31, 2025 1.13 Mn
Dec 31, 2024 1.42 Mn
Dec 31, 2024 1.42 Mn
Sep 30, 2024 1.36 Mn
Sep 30, 2024 1.36 Mn
Jun 30, 2024 959,000.00
Jun 30, 2024 959,000.00
Mar 31, 2024 275,000.00
Mar 31, 2024 275,000.00
Dec 31, 2023 511,000.00
Dec 31, 2023 511,000.00